Advice from experts helps ensure good policy, governance and regulation about immunisation. Some key groups advise the Australian Government on immunisation and assist in making new vaccines available under the National Immunisation Program (NIP).
Office of Health Protection
The Office of Health Protection (OHP), in partnership with key stakeholders, works to protect the health of Australians. The OHP is responsible for managing immunisation programs and policies in line with the Government's preventive health framework. The key priorities of the OHP are to:
- implement the NIP
- secure essential vaccines for the NIP
- implement the National Immunisation Strategy
- develop policy based on evidence from research
- provide technical advice on immunisation
- liaise with the Therapeutic Goods Administration.
Find out more about the OHP.
Australian Technical Advisory Group on Immunisation
The Australian Technical Advisory Group on Immunisation (ATAGI) advises the Minister for Health on the NIP and other issues. In addition to technical experts, the Group’s membership includes a consumer representative, a nurse and general practitioners.
Find out more about the ATAGI.
National Immunisation Committee
The National Immunisation Committee (NIC) provides strategic advice on the NIP and represents the needs and views of vaccination providers and consumers.
The Committee reports to the Australian Health Protection Principal Committee (AHPPC) through the Communicable Diseases Network Australia (CDNA).
Find out more about the NIC.
Therapeutic Goods Administration
The Therapeutic Goods Administration (TGA) works to protect the health of the Australian community through the regulation of therapeutic goods, including:
- medicines, including prescription medicines
- beauty products
- vitamins and minerals
- medical devices
- blood and blood products.
Find out more about the TGA.
Advisory Committee on Vaccines
The Advisory Committee on Vaccines (ACV) provides independent medical and scientific advice to the Minister for Health and the TGA. Its advice focuses on the safety, quality and effectiveness of vaccines supplied in Australia.
Find out more about the ACV.
National Health and Medical Research Council
The National Health and Medical Research Council (NHMRC) provides funding for research to improve medical treatment and the health outcomes of Australians. It draws upon the resources of all components of the health system including:
- medical practitioners
- nurses and allied health professionals
- teaching and research institutions
- public and private program managers
- service administrators
- community health organisations
- social health researchers
Find out more about the NHMRC.
Process for listing new vaccines on the NIP
A number of steps need to occur before a vaccine becomes available on the NIP, including:
- registration of the vaccine by the TGA
- a positive recommendation by the Pharmaceutical Benefits Advisory Committee
- a price agreement between the Department of Health and the pharmaceutical company
- Government approval
- changes to relevant laws
- purchase of the vaccine.
Find out more about the process for listing new vaccines.